Molecular epidemiology of KPC-producing Escherichia coli: Occurrence of ST131-fimH30 subclone harboring pKpQIL-like IncFIIk plasmid

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 7, 2014, Pages 4234-4237

  O'Hara, Jessica A ^a   Hu, Fupin ^a,b,c   Ahn, Chulsoo ^a   Nelson, Jeremy ^a   Rivera, Jesabel I ^a   Pasculle, Anthony W ^a,d   Doi, Yohei ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DORIPENEM; DOXYCYCLINE; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE KPC-2, KLEBSIELLA PNEUMONIAE; BETA-LACTAMASE KPC-3, KLEBSIELLA PNEUMONIAE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; EPIDEMIC; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE CARBAPENEMASE PRODUCING ESCHERICHIA COLI; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; REPLICON; ESCHERICHIA COLI INFECTIONS; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENTAMICINS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; PLASMIDS; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION;

EID: 84903192771     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02182-13     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention. 2013. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb. Mortal. Wkly. Rep. 62:165-170.
2. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S, National Healthcare Safety Network Team (NHSN) Team and Participating NHSN Facilities. 2013. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect. Control Hosp. Epidemiol. 34:1-14. http://dx.doi.org/10.1086/668770.
3. Deshpande LM, Jones RN, Fritsche TR, Sader HS. 2006. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004). Microb. Drug Resist. 12:223-230. http://dx.doi.org/10.1089/mdr.2006.12.223. (Pubitemid 46110652)
4. Kim YA, Qureshi ZA, Adams-Haduch JM, Park YS, Shutt KA, Doi Y. 2012. Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131. Clin. Infect. Dis. 55:224-231. http://dx.doi.org/10.1093/cid/cis387.
5. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Document M07-A9. CLSI, Wayne, PA.
6. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing. Document M100-S24. CLSI, Wayne, PA.
7. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MC, Ochman H, Achtman M. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol. Microbiol. 60: 1136-1151. http://dx.doi.org/10.1111/j.1365-2958.2006.05172.x.
8. Wieler LH, Ewers C, Guenther S, Walther B, Lubke-Becker A. 2011. Methicillin-resistant staphylococci (MRS) and extended-spectrum β-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples. Int. J. Med. Microbiol. 301:635-641. http://dx.doi.org/10.1016/j.ijmm.2011.09.009.
9. Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, Billig M, Riddell K, Rogers P, Qin X, Butler-Wu S, Price LB, Aziz M, Nicolas-Chanoine MH, Debroy C, Robicsek A, Hansen G, Urban C, Platell J, Trott DJ, Zhanel G, Weissman SJ, Cookson BT, Fang FC, Limaye AP, Scholes D, Chattopadhyay S, Hooper DC, Sokurenko EV. 2013. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J. Infect. Dis. 207:919-928. http://dx.doi.org/10. 1093/infdis/jis933.
10. Weissman SJ, Johnson JR, Tchesnokova V, Billig M, Dykhuizen D, Riddell K, Rogers P, Qin X, Butler-Wu S, Cookson BT, Fang FC, Scholes D, Chattopadhyay S, Sokurenko E. 2012. High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl. Environ. Microbiol. 78:1353-1360. http://dx.doi.org/10.1128/AEM.06663-11.
11. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
12. Morris D, Boyle F, Ludden C, Condon I, Hale J, O'Connell N, Power L, Boo TW, Dhanji H, Lavallee C, Woodford N, Cormican M. 2011. Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone. Antimicrob. Agents Chemother. 55:4935-4936. http://dx.doi.org/10.1128/AAC.05127-11.
13. Naas T, Cuzon G, Gaillot O, Courcol R, Nordmann P. 2011. When carbapenem-hydrolyzing β-lactamase KPC meets Escherichia coli ST131 in France. Antimicrob. Agents Chemother. 55:4933-4934. http://dx.doi.org/10.1128/ AAC.00719-11.
14. Doi Y, Paterson DL, Adams-Haduch JM, Sidjabat HE, O'Keefe A, Endimiani A, Bonomo RA. 2009. Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 β-lactamase. Antimicrob. Agents Chemother. 53:3159-3161. http://dx.doi.org/10.1128/AAC.00133- 09.
15. Bueno MF, Francisco GR, O'Hara JA, de Oliveira Garcia D, Doi Y. 2013. Coproduction of 16S rRNA methyltransferase RmtD or RmtG with KPC-2 and CTX-M group extended-spectrum β-lactamases in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 57:2397-2400. http://dx.doi.org/10.1128/AAC.02108-12.
16. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228. http://dx.doi.org/10.1016/j.mimet.2005.03.018. (Pubitemid 41597366)
17. Garcia-Fernandez A, Fortini D, Veldman K, Mevius D, Carattoli A. 2009. Characterization of plasmids harbouring qnrS1, qnrB2 and qnrB19 genes in Salmonella. J. Antimicrob. Chemother. 63:274-281.
18. Villa L, Garcia-Fernandez A, Fortini D, Carattoli A. 2010. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J. Antimicrob. Chemother. 65:2518-2529. http://dx.doi.org/10.1093/jac/dkq347.
19. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial disk susceptibility tests. Approved standard - 11th edition. Clinical and Laboratory Standards Institute, Wayne, PA.
20. Leavitt A, Chmelnitsky I, Carmeli Y, Navon-Venezia S. 2010. Complete nucleotide sequence of KPC-3-encoding plasmid pKpQIL in the epidemic Klebsiella pneumoniae sequence type 258. Antimicrob. Agents Chemother. 54:4493-4496. http://dx.doi.org/10.1128/AAC.00175-10.
21. Darling AE, Mau B, Perna NT. 2010. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One 5:e11147. http://dx.doi.org/10.1371/journal.pone.0011147.
22. Garcia-Fernandez A, Villa L, Carta C, Venditti C, Giordano A, Venditti M, Mancini C, Carattoli A. 2012. Klebsiella pneumoniae ST258 producing KPC-3 identified in Italy carries novel plasmids and OmpK36/OmpK35 porin variants. Antimicrob. Agents Chemother. 56:2143-2145. http://dx.doi.org/10.1128/AAC.05308- 11.
23. Leavitt A, Carmeli Y, Chmelnitsky I, Goren MG, Ofek I, Navon-Venezia S. 2010. Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel. Antimicrob. Agents Chemother. 54:3002-3006. http://dx.doi.org/10.1128/AAC.01818-09.
24. Navon-Venezia S, Leavitt A, Schwaber MJ, Rasheed JK, Srinivasan A, Patel JB, Carmeli Y, Israeli KPC Kpn Study Group. 2009. First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob. Agents Chemother. 53:818-820. http://dx.doi.org/10.1128/AAC.00987- 08.
25. Canton R, Akova M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini GM, Samuelsen O, Seifert H, Woodford N, Nordmann P, European Network on Carbapenemases. 2012. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 18:413-431. http://dx.doi.org/10.1111/j.1469-0691.2012.03821.x.
26. Navon-Venezia S, Chmelnitsky I, Leavitt A, Schwaber MJ, Schwartz D, Carmeli Y. 2006. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob. Agents Chemother. 50:3098-3101. http://dx.doi.org/10.1128/AAC.00438-06. (Pubitemid 44396417)
27. Goren MG, Navon-Venezia S, Chmelnitsky I, Carmeli Y. 2010. Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008. Antimicrob. Agents Chemother. 54:2687-2691. http://dx.doi.org/10.1128/AAC.01359-09.